Page

Job and Legal Notices

Page

Sc(AI)Mitra: Your Agentic AI Co-Scientist

Accelerate biomedical R&D with Sc(AI)Mitra, an Agentic AI co-scientist. Streamline literature reviews, hypothesis generation and complex experimental design.

Page

ProcessIntel

ProcessIntel converts complex processes into agentic AI workflows using SOPs, process data, and expert inputs to automate, optimize, and scale operations.

Page

Automated Pathology Image Analysis with EmPATHy

Accelerate cancer detection and diagnostic accuracy with EmPATHy, an AI-driven solution for automated Whole Slide Image (WSI) analysis and report generation.

Page

DocIntel

DocIntel enables agentic document processing with human-in-the-loop control, turning complex documents into validated data and execution-ready workflows.

Page

Mining Advanced Biomedical Data Insights with Pi-OmniKG

Accelerate life sciences R&D and biomedical data mining with Pi-OmniKG, a GenAI-enabled interactive knowledge graph solution for actionable insights.

Page

Agentic GenMolVS

GenMolVS enables agentic drug discovery by combining generative AI, structure prediction, and virtual screening to accelerate hit identification and optimization.

Page

Pi-AFDD: Persistent’s AlphaFold Drug Discovery

Pi-AFDD accelerates early drug discovery with AlphaFold, predictive AI, and generative modeling to improve target identification and hit discovery.

Page

Events

Register for the latest technology webinars & virtual tech events and watch on-demand webinars on industrial, healthcare, BFSI, & security topics by Persistent Systems

Press Release

Persistent Reports $1,654.4M FY26 Revenue with 17.4% Y-o-Y Growth and 15.6% EBIT Margin

Persistent announced its audited financial results for the quarter ended March 31, 2026, as approved by the Board of Directors.